SCHEMBL24609909

SCHEMBL24609909

c1ccc(-c2ccc3ccc4ccc(-c5cccc(-c6ccc(-c7nc8ccccc8c8ccc9ccc(-c%10ccccc%10)nc9c78)cc6)c5)nc4c3n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 4/20 0.37
▸ PARP1 P09874 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ NQO2 P16083 1/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PDE10A Q9Y233 1/20 0.33
▸ ACACA Q13085 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ NUDT1 P36639 1/20 0.33
▸ DHFR P00374 1/20 0.33
▸ RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24609759 0.95 CYP1A1 (0.39) DHODHPARP1NQO2KDM4ESMN1; SMN2
SCHEMBL24609619 0.94 PARP1 (0.37) DHODHPARP1MEN1KMT2AKDM4E
SCHEMBL24609866 0.94 DHFR (0.40) DHODHPARP1NQO2MEN1KMT2A
SCHEMBL24609617 0.93 MEN1 (0.40) DHODHPARP1ACHEMEN1KMT2A
SCHEMBL24609863 0.93 MEN1 (0.40) DHODHPARP1ACHEMEN1KMT2A
SCHEMBL24609738 0.93 DHODH (0.39) DHODHPARP1ACHENQO2MEN1
SCHEMBL24609837 0.92 TOP1 (0.41) DHODHPARP1KDM4ELMNATDP1
SCHEMBL24609910 0.92 MEN1 (0.39) DHODHPARP1ACHEMEN1KMT2A
SCHEMBL24609612 0.92 MEN1 (0.41) DHODHPARP1ACHENQO2MEN1
SCHEMBL24609761 0.91 PARP1 (0.37) PARP1MEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 DHODH 247/4885PARP1 1028/4885ACHE 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback